Senate Health Care Cost Transparency Initiative Doesn't Mention Drug Pricing, But Likely Can't Avoid It

Bipartisan effort seems more focused on increasing cost transparency for US health care services, but stakeholders still are expected to raise drug pricing issues.

PharmacyReceipt-Dollars-PillBottles_1200x675

The bipartisan group of Senators launching a potentially lengthy effort to deal with US health care cost transparency may have left a big subject (drug pricing) unmentioned although it appears that subject will not be ignored.

Six senators – Republicans Bill Cassidy of Louisiana, Chuck Grassley of Iowa, and Todd Young of Indiana, and Democrats Michael...